361 related articles for article (PubMed ID: 20026874)
1. The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.
Schietke R; Warnecke C; Wacker I; Schödel J; Mole DR; Campean V; Amann K; Goppelt-Struebe M; Behrens J; Eckardt KU; Wiesener MS
J Biol Chem; 2010 Feb; 285(9):6658-69. PubMed ID: 20026874
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.
Wang Y; Ma J; Shen H; Wang C; Sun Y; Howell SB; Lin X
Oncol Rep; 2014 Nov; 32(5):2150-8. PubMed ID: 25174950
[TBL] [Abstract][Full Text] [Related]
4. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
5. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
[TBL] [Abstract][Full Text] [Related]
6. Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression.
Liburkin-Dan T; Toledano S; Neufeld G
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682926
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization.
Canesin G; Cuevas EP; Santos V; López-Menéndez C; Moreno-Bueno G; Huang Y; Csiszar K; Portillo F; Peinado H; Lyden D; Cano A
Oncogene; 2015 Feb; 34(8):951-64. PubMed ID: 24632622
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
10. Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2.
Chen X; Kou Y; Lu Y; Pu Y
J Cell Biochem; 2020 Jan; 121(1):165-173. PubMed ID: 31162697
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.
Xu XH; Jia Y; Zhou X; Xie D; Huang X; Jia L; Zhou Q; Zheng Q; Zhou X; Wang K; Jin LP
Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30804321
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma.
Umezaki N; Nakagawa S; Yamashita YI; Kitano Y; Arima K; Miyata T; Hiyoshi Y; Okabe H; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Cancer Sci; 2019 Jun; 110(6):2033-2043. PubMed ID: 30919528
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional diversity of lysyl oxidase and the LOX-like proteins.
Molnar J; Fong KS; He QP; Hayashi K; Kim Y; Fong SF; Fogelgren B; Szauter KM; Mink M; Csiszar K
Biochim Biophys Acta; 2003 Apr; 1647(1-2):220-4. PubMed ID: 12686136
[TBL] [Abstract][Full Text] [Related]
14. [Effects of lysyl oxidase down-regulation on invasion, migration and E-cadherin protein expression of hypoxic lung cancer cells].
Wei L; Song XR; Sun JJ; Xie L; Wang XW; Lü LY
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(42):3004-7. PubMed ID: 23328296
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
[TBL] [Abstract][Full Text] [Related]
16.
Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143
[TBL] [Abstract][Full Text] [Related]
17. MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.
Moon HJ; Finney J; Xu L; Moore D; Welch DR; Mure M
J Biol Chem; 2013 Oct; 288(42):30000-30008. PubMed ID: 24014025
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
20. LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing
Peng T; Lin S; Meng Y; Gao P; Wu P; Zhi W; Ding W; Cao C; Wu P
Cell Cycle; 2022 Sep; 21(17):1827-1841. PubMed ID: 35509127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
